Skip to content

Candesartan Desethyl Analog

Candesartan Desethyl Analog

Product Description
CAT No.
ALN-C011019
CAS No.
NA
Mol. F.
C22H16N6O3
Mol. Wt.
412.4
Stock
Please Inquire
Chemical Name : 2,3-Dihydro-2-oxo-3-[[2-(2H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-1H-benzimidazole-4-carboxylic acid ;
Smiles : OC(C1=CC=CC(N=C2O)=C1N2CC(C=C3)=CC=C3C4=CC=CC=C4C5=NN=NN5)=O
Inchi : InChI=1/C51H46N6O6/c1-35(62-50(59)63-41-24-13-6-14-25-41)61-48(58)44-28-17-29-45-46(44)56(49(52-45)60-2)34-36-30-32-37(33-31-36)42-26-15-16-27-43(42)47-53-55-57(54-47)51(38-18-7-3-8-19-38,39-20-9-4-10-21-39)40-22-11-5-12-23-40/h3-5,7-12,15-23,26-33,35,41H,6,13-14,24-25,34H2,1-2H3
Synonym : O-Desethyl Candesartan ;

Investigation and structural elucidation of a process related impurity in candesartan cilexetil by LC/ESI-ITMS and NMR

Bhanu Ramana,u2217, Brajesh A. Sharmaa,b, Ganesh Mahale b, Dharmendra Singhb, Ashok KumarnJournal of Pharmaceutical and Biomedical Analysis 56 (2011) 256u2013263

Synergistic suppression of tumor angiogenesis by codelivering of VEGF targeted siRNA and candesartan mediated by functionalized carbon nanovectors

Xuefang Ding, Yujie Su, Cheng Wang, Fangrong Zhang, Kerong Chen, Yu Wang, Min Li, and Wei Wang – ACS Appl. Mater. Interfaces 2017, 9, 28, 23353–23369

Identification, Isolation, and Characterization of Five Potential Degradation Impurities in Candesartan Cilexetil Tablets

Arivozhi Mohan1,&, S. Shanmugavel1 , Ajay Goyal1 , B. R. Venkataraman2 , D. Saravanan – Chromatographia volume 69, pages1211–1220(2009)

Request For Quotation